Apr 10 |
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
|
Apr 9 |
Mainz Biomed Reports Full Year 2023 Financial Results
|
Apr 2 |
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era
|
Mar 19 |
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
|
Mar 18 |
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
|
Mar 12 |
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
|
Mar 8 |
What Makes Mainz Biomed NV (MYNZ) a New Buy Stock
|
Mar 5 |
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
|
Feb 28 |
Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
|
Feb 27 |
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
|